Form 4: Hartford EVP Exercises, Sells HIG Stock Options
Insider Transaction Report
Hartford Insurance Group Executive Vice President Lori A. Rodden exercised stock options and subsequently sold 7,841 shares of common stock on October 29, 2025.
Summary
- Lori A. Rodden, Executive Vice President of Hartford Insurance Group, Inc. (HIG), acquired 7,841 shares of common stock by exercising stock options on October 29, 2025.
- The exercise price for these options was $51.87 per share.
- Concurrently, Rodden sold all 7,841 shares of common stock acquired from the option exercise at a weighted average price of $122.4116 per share.
- The sale prices for the shares ranged from $122.40 to $122.54 per share.
- Following these transactions, Rodden's direct beneficial ownership of common stock is 18,399.962 shares.
- Rodden retains additional stock options with various exercise prices and vesting schedules, including 5,681 options at $51.87, 30,193 options at $69.41, 26,079 options at $78.28, 11,399 options at $95.74, and 9,467 options at $116.41.
Sentiment
Score: 6
Explanation: The transaction reflects an executive realizing value from their compensation, indicating the company's stock has performed well for the vested options. However, the immediate sale of all acquired shares means no increase in the executive's direct equity stake, leading to a neutral to slightly positive sentiment rather than strongly positive.
Positives
- The executive realized a significant gain from the exercise of stock options, with a sale price of $122.4116 per share compared to an exercise price of $51.87 per share, indicating strong appreciation in the company's stock value since the option grant.
- The transaction demonstrates the effectiveness of the company's long-term incentive compensation plan in aligning executive interests with shareholder value creation.
Negatives
- The immediate sale of all shares acquired through the option exercise means the executive did not increase their direct equity stake in the company through this specific transaction.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.
Industry Context
This insider transaction is a routine compensation-related event for an executive and does not provide specific insights into broader industry trends or competitive dynamics within the insurance sector.
Stakeholder Impact
- Shareholders: The transaction involves a minor increase in outstanding shares due to option exercise, immediately offset by the sale. It signals an executive monetizing vested compensation, which is a normal part of executive pay structures.
Key Dates
| Date | Description |
|---|---|
| 02/23/2024 | Stock options with an exercise price of $51.87 became fully exercisable. |
| 02/28/2024 | One-third of stock options with an exercise price of $78.28 became exercisable. |
| 02/23/2025 | Stock options with an exercise price of $69.41 became fully exercisable. |
| 02/27/2025 | One-third of stock options with an exercise price of $95.74 became exercisable. |
| 02/28/2025 | An additional one-third of stock options with an exercise price of $78.28 became exercisable. |
| 10/29/2025 | Date of option exercise and subsequent sale of common stock. |
| 02/25/2026 | One-third of stock options with an exercise price of $116.41 will become exercisable. |
| 02/27/2026 | An additional one-third of stock options with an exercise price of $95.74 will become exercisable. |
| 02/28/2026 | The remaining one-third of stock options with an exercise price of $78.28 will become exercisable. |
| 02/25/2027 | An additional one-third of stock options with an exercise price of $116.41 will become exercisable. |
| 02/27/2027 | The remaining one-third of stock options with an exercise price of $95.74 will become exercisable. |
| 02/25/2028 | The remaining one-third of stock options with an exercise price of $116.41 will become exercisable. |
| 02/23/2031 | Expiration date for the stock options exercised in this transaction. |
| 02/23/2032 | Expiration date for stock options with an exercise price of $69.41. |
| 02/28/2033 | Expiration date for stock options with an exercise price of $78.28. |
| 02/27/2034 | Expiration date for stock options with an exercise price of $95.74. |
| 02/25/2035 | Expiration date for stock options with an exercise price of $116.41. |
Keywords
Hartford Insurance Group, HIG, Insider Trading, Form 4, Stock Options, Executive Compensation, Share Sale, Lori A. Rodden
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.